Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Feng W, Zhou Q, Chen X, et al
The solution maintains a pH range of 4.5 to 7.0, with a target near 5.7, which supports peptide stability across common research compounds
In the 1970s, the first incretin hormone, glucose-dependent insulinotropic polypeptide (GIP), was discovered, and glucagon-like peptide-1 (GLP-1), was subsequently discovered
Anjali Shukla is a supervisory pharmaceutical scientist in the Office of Pharmaceutical Quality, CDER, FDA, and a member of the CDER Emerging Technology Team (ETT)
MT-II was designed and characterised through the systematic melanocortin peptide structure-activity relationship programme in Victor Hrubys laboratory at the University of Arizona , the same programme that produced MT-1 , with the cyclisation strategy introduced to further constrain the pharmacophore into a receptor-binding conformation that simultaneously increases potency, metabolic stability, and the receptor subtype selectivity profile that distinguishes MT-II from the linear tridecapeptide MT-1
US$ 21.79
US$ 23.80
US$ 27.82
US$ 23.41
US$ 27.59
